Navidea Biopharmaceuticals, Inc. (NAVB)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Sep 15, 2025, 3:59 PM EDT
NAVB Market Cap
NAVB has a market cap or net worth of $50.00 thousand as of September 16, 2025. Its market cap has decreased by -98.86% in one year.
Market Cap
50.00K
Enterprise Value
n/a
Revenue
610.00
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 10, 1992, NAVB's market cap has decreased from 4.93M to 50.00K, a decrease of -98.99%. That is a compound annual growth rate of -13.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 50.00K | 400.02% |
| Dec 31, 2024 | 10.00K | -99.82% |
| Dec 29, 2023 | 5.52M | -18.56% |
| Dec 30, 2022 | 6.78M | -77.52% |
| Dec 31, 2021 | 30.15M | -47.33% |
| Dec 31, 2020 | 57.25M | 151.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |